Qilian Mountains

Qilian International Holding Group Limited Enters into Investment Agreement for Pig By-product Processing Project in Chongqing

Retrieved on: 
Friday, July 9, 2021
Western China, Administrative divisions of China, Geography of China, Glycosaminoglycans, Heparins, Geography of Asia, Chongqing, Gansu, Qilian Mountains, Pork

The Project is expected to receive preferential policies from the government at the national, municipal and local levels.

Key Points: 
  • The Project is expected to receive preferential policies from the government at the national, municipal and local levels.
  • Mr. Zhanchang Xin, Chairman and CEO of the Company, commented, We are very pleased to work with CJT on the Project.
  • As a key area for pig breeding and pork production in China, Chongqing has sufficient raw materials for the production of heparin sodium preparations.
  • Qilian International Holding Group Limited, headquartered in Gansu, China, is a pharmaceutical and chemical products manufacturer in China.

Qilian International Holding Group Limited CEO Receives Outstanding Entrepreneur Award

Retrieved on: 
Thursday, February 18, 2021
Sites along the Silk Road, Gansu, Inner Asia, MONGOLIA, Western China, Qilian Mountains, East Asia, Geography of Asia, Asia

Jiuquan, China, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the Company), a China-based pharmaceutical and chemical products manufacturer, today announced that its Chairman and Chief Executive Officer, Mr. Zhanchang Xin, received the Outstanding Entrepreneur Award from the Economic and Technological Development Zone of Jiuquan City in February 2021.

Key Points: 
  • Jiuquan, China, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the Company), a China-based pharmaceutical and chemical products manufacturer, today announced that its Chairman and Chief Executive Officer, Mr. Zhanchang Xin, received the Outstanding Entrepreneur Award from the Economic and Technological Development Zone of Jiuquan City in February 2021.
  • The Outstanding Entrepreneur Award is presented to chief executive officers of businesses in a wide range of industries and sectors with leadership skills, innovation, and entrepreneurial vision.
  • Mr. Xin commented: I am honored to receive the Outstanding Entrepreneur Award and I am proud of all the work our team has done over the years to make it happen.
  • Qilian International Holding Group Limited, headquartered in Gansu, China, is a pharmaceutical and chemical products manufacturer.

Qilian International Holding Group Limited to Triple Organic Fertilizer Production Capacity by March 2021

Retrieved on: 
Monday, February 8, 2021
Fertilizer, Gansu, Organic fertilizer, Organic food, Qilian Mountains, East Asia, Articles, Geography

The Company expects to triple its organic fertilizer production capacity upon completion of its first phase expansion.

Key Points: 
  • The Company expects to triple its organic fertilizer production capacity upon completion of its first phase expansion.
  • With a tripled production capacity, the Company has won bids for government organic fertilizer projects in Tibet, Gansu and Qinghai.
  • As each mu of arable land consumes 150-200 kilograms of organic fertilizer, the organic fertilizer market in China has tremendous potential.
  • Qilian International Holding Group Limited, headquartered in Gansu, China, is a pharmaceutical and chemical products manufacturer in China.

Qilian International Holding Group Limited Announces Closing of Initial Public Offering

Retrieved on: 
Friday, January 15, 2021
Gansu, Inner Asia, MONGOLIA, Western China, Qilian Mountains, Underwriting, East Asia, Geography of Asia, Asia

Jiuquan, China, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (the Company) (Nasdaq: QLI), a China-based pharmaceutical and chemical products manufacturer, today announced the closing of its initial public offering ("Offering") of 5,000,000 ordinary shares at a public offering price of US$5.00 per share.

Key Points: 
  • Jiuquan, China, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (the Company) (Nasdaq: QLI), a China-based pharmaceutical and chemical products manufacturer, today announced the closing of its initial public offering ("Offering") of 5,000,000 ordinary shares at a public offering price of US$5.00 per share.
  • The Company received aggregate gross proceeds of US$25 million from this Offering, before deducting underwriting discounts and other related expenses.
  • Qilian International Holding Group Limited, headquartered in Gansu, China, is a pharmaceutical and chemical products manufacturer in China.
  • All statements other than statements of historical fact in this announcement are forward-looking statements, including but not limited to, the Company's proposed Offering.

ATIF Holdings Limited Announces Its IPO Client Soars 100% in the U.S. Trading Debut

Retrieved on: 
Wednesday, January 13, 2021
Qilian Mountains, Sites along the Silk Road, Gansu, East Asia, Geography of Asia, Asia

LOS ANGELES, Jan. 13, 2021 /PRNewswire/ -- ATIF Holdings Limited (Nasdaq: ATIF,"ATIF"), a company providing business consulting and media services in Asiaand North America,announces the client of ATIF, a China-based pharmaceutical and chemical products manufacturer, Qilian International Holding Group Limited (Nasdaq: QLI,"Qilian"), has made a powerful debut with its IPO on January 12, 2021.

Key Points: 
  • LOS ANGELES, Jan. 13, 2021 /PRNewswire/ -- ATIF Holdings Limited (Nasdaq: ATIF,"ATIF"), a company providing business consulting and media services in Asiaand North America,announces the client of ATIF, a China-based pharmaceutical and chemical products manufacturer, Qilian International Holding Group Limited (Nasdaq: QLI,"Qilian"), has made a powerful debut with its IPO on January 12, 2021.
  • Qilian announced the pricing of its initial public offering of 5,000,000 ordinary shares at a public offering price of US$5.00 per share on January 12, 2021.
  • Qilian expects to receive aggregate gross proceeds of US$25 million from this Offering, before deducting underwriting discounts and other related expenses.
  • Qilian International Holding Group Limited, headquartered in Gansu, China, is a pharmaceutical and chemical products manufacturer in China.

ATIF Holdings Limited Announces Its Client Listing on the Nasdaq Global Market on January 12, 2021

Retrieved on: 
Tuesday, January 12, 2021
Qilian Mountains, Sites along the Silk Road, Initial public offering, Gansu, East Asia, Geography of Asia, Asia

Qilian announced the pricing of its initial public offering ("Offering") of 5,000,000 ordinary shares at a public offering price of US$5.00 per share on January 12, 2021.

Key Points: 
  • Qilian announced the pricing of its initial public offering ("Offering") of 5,000,000 ordinary shares at a public offering price of US$5.00 per share on January 12, 2021.
  • Qilian expects to receive aggregate gross proceeds of US$25 million from this Offering, before deducting underwriting discounts and other related expenses.
  • The Offering is expected to close on or about January 14, 2021, subject to the satisfaction of customary closing conditions.
  • Qilian International Holding Group Limited, headquartered in Gansu, China, is a pharmaceutical and chemical products manufacturer in China.

Qilian International Holding Group Limited Announces Pricing of Initial Public Offering

Retrieved on: 
Tuesday, January 12, 2021
Qilian Mountains, Sites along the Silk Road, Initial public offering, Gansu, Pricing, East Asia, Geography of Asia, Asia

Jiuquan, China, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (the Company), a China-based pharmaceutical and chemical products manufacturer, today announced the pricing of its initial public offering ("Offering") of 5,000,000 ordinary shares at a public offering price of US$5.00 per share.

Key Points: 
  • Jiuquan, China, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (the Company), a China-based pharmaceutical and chemical products manufacturer, today announced the pricing of its initial public offering ("Offering") of 5,000,000 ordinary shares at a public offering price of US$5.00 per share.
  • In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 750,000 ordinary shares at the public offering price, less underwriting discounts.
  • The Offering is expected to close on or about January 14, 2021, subject to the satisfaction of customary closing conditions.
  • Qilian International Holding Group Limited, headquartered in Gansu, China, is a pharmaceutical and chemical products manufacturer in China.